David A Ford Selected Research

David A Ford Research Topics

Disease

14	Inflammation (Inflammations) 07/2020 - 02/2002
12	Atherosclerosis 01/2019 - 09/2003
7	Sepsis (Septicemia) 01/2022 - 12/2017
6	Neoplasms (Cancer) 01/2021 - 01/2018
5	Obesity 12/2021 - 01/2013
4	Body Weight (Weight, Body) 12/2021 - 04/2015
4	Lung Injury 01/2021 - 01/2020
4	Atherosclerotic Plaque (Atheroma) 08/2013 - 12/2003
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 12/2017
3	Insulin Resistance 12/2021 - 06/2015
3	Acute Lung Injury 05/2021 - 01/2020
3	Melanoma (Melanoma, Malignant) 01/2021 - 01/2019
3	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2018
3	Wounds and Injuries (Trauma) 11/2020 - 01/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2014 - 09/2009
2	Infections 01/2022 - 07/2013
2	Pre-Eclampsia (Preeclampsia) 05/2021 - 01/2017
2	Hemolysis 01/2021 - 01/2020
2	Mouth Neoplasms (Oral Cancer) 11/2019 - 10/2019
2	Ischemia 01/2019 - 01/2019
2	Gallstones (Gallstone) 06/2017 - 04/2015
2	Pulmonary Alveolar Proteinosis 01/2017 - 12/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2013 - 12/2003
2	Coronary Disease (Coronary Heart Disease) 08/2013 - 01/2012
2	Myocardial Infarction 01/2012 - 06/2005
2	Infarction (Infarctions) 01/2012 - 06/2005
1	COVID-19 01/2022
1	Respiratory Acidosis 01/2021
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021
1	Acute Chest Syndrome 01/2021
1	Tularemia 07/2020
1	Herpes Zoster 01/2020
1	Pulmonary Edema 01/2020
1	Hemorrhagic Shock 01/2019
1	Heart Failure 01/2019
1	Progeria (Hutchinson Gilford Syndrome) 01/2019

Drug/Important Bio-Agent (IBA)

19	LipidsIBA 01/2022 - 09/2009
12	Peroxidase (Myeloperoxidase)IBA 12/2021 - 09/2003
10	CholesterolIBA 12/2021 - 05/2008
8	PlasmalogensIBA 01/2022 - 02/2002
7	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022 - 10/2002
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2009
4	HalogensIBA 05/2021 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 11/2020 - 10/2019
4	AcidsIBA 11/2020 - 09/2014
4	AldehydesIBA 01/2020 - 02/2002
3	Insulin (Novolin)FDA Link 12/2021 - 10/2014
3	EnzymesIBA 01/2021 - 01/2012
3	BromineIBA 11/2020 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 10/2014
3	Triglycerides (Triacylglycerol)IBA 03/2016 - 10/2013
2	CytokinesIBA 01/2022 - 01/2020
2	Tyrosine (L-Tyrosine)FDA Link 05/2021 - 01/2017
2	Heme (Haem)IBA 01/2021 - 01/2020
2	oxidized low density lipoproteinIBA 01/2021 - 09/2003
2	ChlorineIBA 01/2021 - 01/2016
2	HemopexinIBA 01/2021 - 01/2020
2	Lipoproteins (Lipoprotein)IBA 01/2021 - 08/2013
2	Messenger RNA (mRNA)IBA 10/2019 - 10/2013
2	CarbohydratesIBA 03/2016 - 06/2015
2	ApolipoproteinsIBA 04/2015 - 10/2013
2	CalciumIBA 09/2014 - 07/2013
2	Phosphotransferases (Kinase)IBA 11/2013 - 08/2013
2	Phospholipases (Phospholipase)IBA 07/2013 - 01/2012
2	2-chlorohexadecanalIBA 07/2008 - 06/2006
1	K-18 conjugate (K18)IBA 01/2022
1	1,2-Dipalmitoylphosphatidylcholine (Dipalmitoylphosphatidylcholine)IBA 01/2022
1	phosphatidal ethanolaminesIBA 12/2021
1	FructoseIBA 12/2021
1	Choline (Choline Chloride)IBA 12/2021
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 05/2021
1	Stearic AcidsIBA 01/2021
1	Heme Oxygenase-1IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Group IV Phospholipases A2IBA 01/2021
1	5-hydroxy-6,8,11,14-eicosatetraenoic acidIBA 07/2020
1	VaccinesIBA 07/2020
1	Biological ProductsIBA 07/2020
1	Lipoxygenase (Lipoxygenase-1)IBA 07/2020
1	HydrazinesIBA 01/2020
1	N-acetyllysyltyrosylcysteine amideIBA 01/2020
1	Mast Cell StabilizersIBA 01/2020
1	4-Aminobenzoic Acid (4 Aminobenzoic Acid)IBA 01/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2020
1	SpectrinIBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	ChemokinesIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Epithelial Sodium ChannelsIBA 01/2020
1	Pyruvic Acid (Pyruvate)IBA 10/2019
1	CarcinogensIBA 10/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2019
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2019
1	CalpainIBA 01/2019

Therapy/Procedure

8	Therapeutics 01/2021 - 06/2017
3	Immunotherapy 01/2021 - 01/2019
3	bitter melon extract 11/2019 - 11/2018
2	Ligation 01/2020 - 01/2012
1	Intramuscular Injections 01/2020
1	Punctures 01/2020